JA NHCP EVO ICL SIGNED_Redacted.pdf

This document is a Justification and Approval (J&A) for a Sole Source Acquisition for the Defense Health Agency's Healthcare Contracting Division at Naval Hospital Camp Pendleton. The procurement is for EVO Implantable Collamer Lens (ICL) from Staar Surgical Co., the only manufacturer and distributor meeting the specific requirements for ophthalmologic refractive surgery needs. The Blanket Purchase Agreement (BPA) will cover the period from 1 May 2025 to 30 April 2028, with a firm-fixed-price contract type and funding from Operations and Maintenance (O&M).

The document details that Staar Surgical is the sole source for specialized EVO ICLs, which are thin, soft, organic biocompatible lenses used for correcting refractive errors in younger patients with high degrees of nearsightedness. Extensive market research confirmed no other vendors can provide these specialized lenses. The procurement is specifically tailored to meet individual patient needs, with the ophthalmology department prioritizing patient well-being by selecting the most appropriate lens type (ICL or IOL) based on specific patient characteristics such as age, vision requirements, and surgical candidacy.